The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients.

Matthew ParsonsShane LloydSkyler JohnsonCourtney ScaifeHeloisa SoaresRebecca KimRobin KimIgnacio Garrido-LagunaRanda Tao

Published in: Journal of gastrointestinal cancer (2022)

We identified characteristics that are related to the timing of adjuvant therapy in patients with biliary cancers. There was an OS decrement associated with delays beyond the median time point of 59 days. This finding may be especially relevant given the treatment delays seen as a result of COVID-19.

Keyphrases

end stage renal disease
coronavirus disease
sars cov
ejection fraction
prognostic factors
newly diagnosed
lymph node
peritoneal dialysis
respiratory syndrome coronavirus
smoking cessation